Next-Generation Sequencing
Arima Genomics to Offer NGS-Based Gene Fusion Test Through Protean BioDiagnostics CLIA Lab
Under the agreement, the Arima Gene Fusion Test will become available in the first half of this year through Protean BioDiagnostics' laboratory in Orlando, Florida.
Labcorp, VieCure Collaborate on NGS, Software for Cancer Diagnosis
Startup oncology bioinformatics firm VieCure expects this collaboration to bring precision oncology diagnostics and treatment to more community clinics.
Foundation Medicine, Boehringer Ingelheim Collaborate on CDx for Biliary Tract Cancer Drug
The companies will develop the FoundationOne CDx test as a companion diagnostic for Boehringer Ingelheim's BI 907828 in the US, Japan, and EU.
Absent Resolution on FDA's LDT Oversight in 2022, Some Payors Began Advancing Their Own Requirements
Premium
After the VALID Act didn't pass, it's uncertain how the FDA will proceed, though some payors aren't waiting for the status quo to change and asking labs to submit additional validation data on cancer tests.
MDIC, Horizon Discovery Partner on Reference Samples for NGS-Based Cancer Tests
The partners agreed to develop and make somatic reference samples that could simplify and support validation of cancer assays, and they expect the samples will be available by early 2024.